Condition
Medullary Thyroid Carcinoma clinical trials and research
As of November 12, 2026, Find a Trial lists 4 Medullary Thyroid Carcinoma clinical trials that are recruiting, at sites in 5 countries (most in China (3), Canada (1), Japan (1)). 1 was first registered in the last 30 days. By phase: Phase 1 (1), Phase 3 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 4Clinical trials
- 1New in 30 days
- 5Countries
Newest Medullary Thyroid Carcinoma clinical trials
| Study | Phase | Where | Status | Registered |
|---|---|---|---|---|
| 68Ga-YQ-CC05: a new probe for detecting tumors with CCK2R | — | Nanjing, Jiangsu | Recruiting | Nov 4, 2026 |
| Precision surgery guided by 68Ga-CTR-FAPI for newly diagnosed medullary thyroid cancer | Phase 3 | Beijing, Beijing Municipality | Recruiting | Feb 3, 2026 |
| 68Ga-DOTA-CCK-FS PET/CT imaging for medullary thyroid cancer | — | Beijing, Beijing Municipality | Recruiting | Aug 24, 2025 |
| Phase I testing of 225Ac-ETN029 for advanced DLL3-positive tumors | Phase 1 | Iowa City, Iowa and 7 other locations | Recruiting | Jun 5, 2025 |
All recruiting trials (4)
-
68Ga-YQ-CC05: a new probe for detecting tumors with CCK2R
This study tests a radioactive probe called 68Ga-YQ-CC05 to see if it can safely help find tumors in adults with certain cancers using PET-CT imaging.
-
Precision surgery guided by 68Ga-CTR-FAPI for newly diagnosed medullary thyroid cancer
This trial will test whether using 68Ga-CTR-FAPI PET-CT to guide the extent of surgery improves biochemical cure rates for people with newly diagnosed medullary thyroid carcinoma.
-
68Ga-DOTA-CCK-FS PET/CT imaging for medullary thyroid cancer
This trial will test whether a new PET tracer, 68Ga-DOTA-CCK-FS, can better find medullary thyroid cancer and other CCK-2R–positive tumors than standard PET scans.
-
Phase I testing of 225Ac-ETN029 for advanced DLL3-positive tumors
This trial will test 225Ac-ETN029, with 111In-ETN029 used for imaging, to see if the treatment is safe, tolerable, and shows early anti-tumor activity in adults with advanced DLL3-positive neuroendocrine cancers.
Related topics
Quick answers
How many Medullary Thyroid Carcinoma clinical trials are recruiting right now?
4, as of November 12, 2026. 1 of them was first registered in the last 30 days. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 5 countries. The most sites are in China (3 trials), Canada (1 trial), Japan (1 trial), South Korea (1 trial), United States (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 1: 1, Phase 3: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.